Massavon W, Barlow-Mosha L, Mugenyi L, McFarland W, Gray G, Lundin R, Costenaro P, Nannyonga M M, Penazzato M, Bagenda D, Namisi C P, Wabwire D, Mubiru M, Kironde S, Bilardi D, Mazza A, Fowler M G, Musoke P, Giaquinto C
Department of Paediatrics, University of Padua, Via Giustiniani 3, 35128 Padua, Italy ; St. Raphael of St. Francis Hospital (Nsambya Hospital), Kampala, Uganda.
Makerere University, Johns Hopkins University Research Collaboration, Kampala, Uganda.
ISRN AIDS. 2014 Apr 1;2014:852489. doi: 10.1155/2014/852489. eCollection 2014.
We describe factors determining retention and survival among HIV-infected children and adolescents engaged in two health care delivery models in Kampala, Uganda: one is a community home-based care (CHBC) and the other is a facility-based family-centred approach (FBFCA). This retrospective cohort study reviewed records from children aged from 0 to 18 years engaged in the two models from 2003 to 2010 focussing on retention/loss to follow-up, mortality, use of antiretroviral therapy (ART), and clinical characteristics. Kaplan Meier survival curves with log rank tests were used to describe and compare retention and survival. Overall, 1,623 children were included, 90.0% (1460/1623) from the CHBC. Children completed an average of 4.2 years of follow-up (maximum 7.7 years). Median age was 53 (IQR: 11-109) months at enrolment. In the CHBC, retention differed significantly between patients on ART and those not (log-rank test, adjusted, P < 0.001). Comparing ART patients in both models, there was no significant difference in long-term survival (log-rank test, P = 0.308, adjusted, P = 0.489), while retention was higher in the CHBC: 94.8% versus 84.7% in the FBFCA (log-rank test, P < 0.001, adjusted P = 0.006). Irrespective of model of care, children receiving ART had better retention in care and survival.
一种是社区居家护理(CHBC),另一种是基于医疗机构的家庭中心护理方法(FBFCA)。这项回顾性队列研究回顾了2003年至2010年参与这两种模式的0至18岁儿童的记录,重点关注随访的留存/失访情况、死亡率、抗逆转录病毒疗法(ART)的使用以及临床特征。使用带有对数秩检验的Kaplan Meier生存曲线来描述和比较留存率及生存率。总体而言,共纳入1623名儿童,其中90.0%(1460/1623)来自CHBC。儿童平均随访了4.2年(最长7.7年)。入组时的中位年龄为53(四分位间距:11 - 109)个月。在CHBC中,接受ART治疗的患者与未接受治疗的患者之间的留存率存在显著差异(对数秩检验,校正后,P < 0.001)。比较两种模式下接受ART治疗的患者,长期生存率无显著差异(对数秩检验,P = 0.308,校正后,P = 0.489),而CHBC的留存率更高:分别为94.8%和84.7%(对数秩检验),P < 0.001,校正后P = 0.006)。无论护理模式如何,接受ART治疗的儿童在护理中的留存率和生存率更高。